INS and diabetes mellitus: Thus, inhibition of calcineurin leads to decreased insulin transcription [42,43] and, then, to post-transplantation Diabetes mellitus – PTDM [44], the most known adverse effect caused by immunosuppressive treatment with tacrolimus [1,6,7].